Defence Therapeutics Inc.
DTC
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 280.76% | -65.88% | -90.27% | -98.04% | -82.13% |
| Total Receivables | 36.69% | -42.31% | -45.41% | -37.61% | -31.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -93.66% | -85.41% | -61.08% | -88.00% | -28.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 220.11% | -66.56% | -86.79% | -93.97% | -79.10% |
|
|
|||||
| Total Current Assets | 220.11% | -66.56% | -86.79% | -93.97% | -79.10% |
| Net Property, Plant & Equipment | -38.51% | 92.72% | 327.99% | 330.87% | 437.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -10.03% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 129.95% | -44.70% | -73.22% | -86.91% | -69.27% |
|
|
|||||
| Total Accounts Payable | -32.62% | 43.92% | 479.05% | 954.97% | 1,067.45% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.29% | -21.96% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -31.32% | 1,709.60% | 3,702.97% | 657.14% | 37.68% |
| Total Other Current Liabilities | -31.32% | 1,709.60% | 3,702.97% | 657.14% | 37.68% |
| Total Current Liabilities | -25.12% | 20.34% | 1,062.65% | 1,679.04% | 1,752.01% |
|
|
|||||
| Total Current Liabilities | -25.12% | 20.34% | 1,062.65% | 1,679.04% | 1,752.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.47% | 19.43% | 124.28% | 99.85% | 79.48% |
|
|
|||||
| Common Stock & APIC | -1.92% | 3.82% | 12.34% | 9.83% | 27.58% |
| Retained Earnings | 6.27% | 5.55% | -59.25% | -70.58% | -86.27% |
| Treasury Stock & Other | 9.60% | -43.37% | 365.27% | 343.76% | 337.09% |
| Total Common Equity | 90.99% | -38.10% | -834.56% | -321.43% | -272.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.99% | -38.10% | -834.56% | -321.43% | -272.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.99% | -38.10% | -834.56% | -321.43% | -272.46% |
|
|
|||||